Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanyan Meng

Showing results (61-70 of 88) with videos related to

Pageof 9
Sort By:
Bioengineering & Translational Medicine|November 29, 2023
Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumorRuihan Xu, Qin Wang, Junmeng Zhu, et al.
Drug Delivery|March 4, 2021
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cellsQin Wang, Ying-Tzu Yen, Chen Xie, et al.
Viruses|October 27, 2022
Isolation, Identification, and Genetic Phylogenetic Analysis of Two Different Genotypes of Bovine Parainfluenza 3 Virus in ChinaXu Wang, Jianjun Hu, Fanyan Meng, et al.
Oncotargets and Therapy|December 10, 2019
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric CancerJu Yang, Jing Yan, Jie Shao, et al.
International Journal of Oncology|September 14, 2017
Cooperative oncogenic effect and cell signaling crosstalk of co‑occurring HER2 and mutant PIK3CA in mammary epithelial cellsLun Dong, Fanyan Meng, Ling Wu, et al.
Cellular Immunology|July 7, 2026
Corrigendum to "Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer" [Cell. Immunol. 365 (2021) 104376]Shiyao Du, Huizi Sha, Naiqing Ding, et al.
Journal of Translational Medicine|September 12, 2023
Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapyZhichen Sun, Yanhong Chu, Jie Xiao, et al.
Cellular Immunology|May 13, 2021
Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancerShiyao Du, Huizi Sha, Naiqing Ding, et al.
International Journal of Nanomedicine|September 27, 2018
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant proteinHong Chen, Huizi Sha, Lianru Zhang, et al.
Advanced Healthcare Materials|July 26, 2024
An Immunomodulator-Boosted Lactococcus Lactis Platform For Enhanced In Situ Tumor VaccineMengna Sun, Tianyu Shi, Subiyinuer Tuerhong, et al.
Pageof 9

Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Bioengineering & Translational Medicine|November 29, 2023
Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumorRuihan Xu, Qin Wang, Junmeng Zhu, et al.
Drug Delivery|March 4, 2021
Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cellsQin Wang, Ying-Tzu Yen, Chen Xie, et al.
Viruses|October 27, 2022
Isolation, Identification, and Genetic Phylogenetic Analysis of Two Different Genotypes of Bovine Parainfluenza 3 Virus in ChinaXu Wang, Jianjun Hu, Fanyan Meng, et al.
Oncotargets and Therapy|December 10, 2019
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric CancerJu Yang, Jing Yan, Jie Shao, et al.
International Journal of Oncology|September 14, 2017
Cooperative oncogenic effect and cell signaling crosstalk of co‑occurring HER2 and mutant PIK3CA in mammary epithelial cellsLun Dong, Fanyan Meng, Ling Wu, et al.
Cellular Immunology|July 7, 2026
Corrigendum to "Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer" [Cell. Immunol. 365 (2021) 104376]Shiyao Du, Huizi Sha, Naiqing Ding, et al.
Journal of Translational Medicine|September 12, 2023
Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapyZhichen Sun, Yanhong Chu, Jie Xiao, et al.
Cellular Immunology|May 13, 2021
Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancerShiyao Du, Huizi Sha, Naiqing Ding, et al.
International Journal of Nanomedicine|September 27, 2018
Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant proteinHong Chen, Huizi Sha, Lianru Zhang, et al.
Advanced Healthcare Materials|July 26, 2024
An Immunomodulator-Boosted Lactococcus Lactis Platform For Enhanced In Situ Tumor VaccineMengna Sun, Tianyu Shi, Subiyinuer Tuerhong, et al.
Pageof 9